TCA
HZNP

Troluce Capital Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-25,002
Closed -$2.89M 60
2023
Q3
$2.89M Buy
+25,002
New +$2.89M 1.09% 16